These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19332675)

  • 1. Topoisomerase I gene mutations at F270 in the large subunit and N184 in the small subunit contribute to the resistance mechanism of the unicellular parasite Leishmania donovani towards 3,3'-diindolylmethane.
    Roy A; BoseDasgupta S; Ganguly A; Jaisankar P; Majumder HK
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2589-98. PubMed ID: 19332675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of derivatives of 3, 3'-diindolylmethane as potent Leishmania donovani bi-subunit topoisomerase IB poisons.
    Roy A; Chowdhury S; Sengupta S; Mandal M; Jaisankar P; D'Annessa I; Desideri A; Majumder HK
    PLoS One; 2011; 6(12):e28493. PubMed ID: 22174820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3'-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme.
    Roy A; Das BB; Ganguly A; Bose Dasgupta S; Khalkho NV; Pal C; Dey S; Giri VS; Jaisankar P; Dey S; Majumder HK
    Biochem J; 2008 Jan; 409(2):611-22. PubMed ID: 17922678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3'-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani.
    Roy A; Ganguly A; BoseDasgupta S; Das BB; Pal C; Jaisankar P; Majumder HK
    Mol Pharmacol; 2008 Nov; 74(5):1292-307. PubMed ID: 18703668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topoisomerase I amino acid substitutions, Gly185Arg and Asp325Glu, confer camptothecin resistance in Leishmania donovani.
    Marquis JF; Hardy I; Olivier M
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1441-6. PubMed ID: 15793124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I.
    Das BB; Sen N; Roy A; Dasgupta SB; Ganguly A; Mohanta BC; Dinda B; Majumder HK
    Nucleic Acids Res; 2006; 34(4):1121-32. PubMed ID: 16488884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational study of the "catalytic tetrad" of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: Role of Asp-353 and Asn-221 in camptothecin resistance.
    Diaz-González R; Pérez-Pertejo Y; Pommier Y; Balaña-Fouce R; Reguera RM
    Biochem Pharmacol; 2008 Sep; 76(5):608-19. PubMed ID: 18655776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo.
    Saha S; Mukherjee T; Chowdhury S; Mishra A; Chowdhury SR; Jaisankar P; Mukhopadhyay S; Majumder HK
    Biochem Pharmacol; 2013 Dec; 86(12):1673-87. PubMed ID: 24134912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites both In Vitro and In Vivo by Targeting Type IB Topoisomerase.
    Saha S; Acharya C; Pal U; Chowdhury SR; Sarkar K; Maiti NC; Jaisankar P; Majumder HK
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6281-93. PubMed ID: 27503653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB.
    Chowdhury SR; Kumar A; Godinho JLP; De Macedo Silva ST; Zuma AA; Saha S; Kumari N; Rodrigues JCF; Sundar S; Dujardin JC; Roy S; De Souza W; Mukhopadhyay S; Majumder HK
    Biochem Pharmacol; 2017 Aug; 138():19-30. PubMed ID: 28483460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational studies reveal lysine 352 on the large subunit is indispensable for catalytic activity of bi-subunit topoisomerase I from Leishmania donovani.
    Ganguly A; Sengupta S; Bosedasgupta S; Roy A; Majumder HK
    Mol Biochem Parasitol; 2009 May; 165(1):57-66. PubMed ID: 19393162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits.
    Lee H; Baek KH; Phan TN; Park IS; Lee S; Kim J; No JH
    Biochem Biophys Res Commun; 2021 Sep; 569():193-198. PubMed ID: 34256188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pentapeptide signature motif plays a pivotal role in Leishmania DNA topoisomerase IB activity and camptothecin sensitivity.
    Prada CF; Alvarez-Velilla R; Diaz-González R; Prieto C; Pérez-Pertejo Y; Balaña-Fouce R; Reguera RM
    Biochim Biophys Acta; 2012 Dec; 1820(12):2062-71. PubMed ID: 23000572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal region of the large subunit of Leishmania donovani bisubunit topoisomerase I is involved in DNA relaxation and interaction with the smaller subunit.
    Das BB; Sen N; Dasgupta SB; Ganguly A; Majumder HK
    J Biol Chem; 2005 Apr; 280(16):16335-44. PubMed ID: 15711017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assignment of UV-vis spectrum of (3,3')-diindolylmethane, a Leishmania donovani topoisomerase IB inhibitor and a candidate DNA minor groove binder.
    Coletta A; Morozzo della Rocca B; Jaisankar P; Majumder HK; Chillemi G; Sanna N; Desideri A
    J Phys Chem A; 2010 Jul; 114(26):7121-6. PubMed ID: 20550156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan.
    Rosa-Teijeiro C; Wagner V; Corbeil A; d'Annessa I; Leprohon P; do Monte-Neto RL; Fernandez-Prada C
    Parasit Vectors; 2021 Aug; 14(1):438. PubMed ID: 34454601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel betulin derivatives as antileishmanial agents with mode of action targeting type IB DNA topoisomerase.
    Chowdhury S; Mukherjee T; Sengupta S; Chowdhury SR; Mukhopadhyay S; Majumder HK
    Mol Pharmacol; 2011 Oct; 80(4):694-703. PubMed ID: 21750153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance mechanism development to the topoisomerase-I inhibitor Hoechst 33342 by Leishmania donovani.
    Marquis JF; Hardy I; Olivier M
    Parasitology; 2005 Aug; 131(Pt 2):197-206. PubMed ID: 16145936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP independent type IB topoisomerase of Leishmania donovani is stimulated by ATP: an insight into the functional mechanism.
    Sengupta S; Ganguly A; Roy A; Bosedasgupta S; D'Annessa I; Desideri A; Majumder HK
    Nucleic Acids Res; 2011 Apr; 39(8):3295-309. PubMed ID: 21186185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania donovani: differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays.
    Jean-Moreno V; Rojas R; Goyeneche D; Coombs GH; Walker J
    Exp Parasitol; 2006 Jan; 112(1):21-30. PubMed ID: 16293247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.